Table 4: Distribution of patients according to the serological status of the source patient and the consulting patient.
Serology |
HIV+ N (%) |
HIV– N (%) |
Not done/unknown N (%) |
Source person* |
264 (44) |
35 (5.8) |
301 (50.2) |
Consulting patient** |
14 (2.3) |
571 (95.2) |
15 (2.5) |
*Source person: Person from whom the potentially contaminated biological product (professional AEB) comes or from whom the non-professional AEB comes; **Consulting patient: Person victim of AEB.